Opexa Therapeutics, Inc.·4

Mar 4, 5:35 PM ET

Opexa Therapeutics, Inc. 4

4 · Opexa Therapeutics, Inc. · Filed Mar 4, 2014

Insider Transaction Report

Form 4
Period: 2014-02-28
Transactions
  • Award

    Stock Option (Right to Buy)

    2014-02-28+17,68617,686 total
    Exercise: $1.82Exp: 2024-02-28Common Stock (17,686 underlying)
  • Award

    Stock Option (Right to Buy)

    2014-02-28+5,8965,896 total
    Exercise: $1.82Exp: 2024-02-28Common Stock (5,896 underlying)
  • Award

    Stock Option (Right to Buy)

    2014-02-28+8,8448,844 total
    Exercise: $1.82Exp: 2024-02-28Common Stock (8,844 underlying)
Footnotes (3)
  • [F1]50% excercisable on grant date of February 28, 2014 and the balance vests on December 31, 2014.
  • [F2]50% excercisable on grant date of February 28, 2014 and the balance vests on February 28, 2015.
  • [F3]25% vests on each of March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4